tiprankstipranks
Advertisement
Advertisement
XTL Biopharmaceuticals Faces Added Nasdaq Delisting Risk Over Late 2025 Annual Report
PremiumCompany AnnouncementsXTL Biopharmaceuticals Faces Added Nasdaq Delisting Risk Over Late 2025 Annual Report
3M ago
XTL Biopharmaceuticals Calls June 22, 2026 Meeting to Approve Psyga Bio Acquisition and Capital Raise
Premium
Company Announcements
XTL Biopharmaceuticals Calls June 22, 2026 Meeting to Approve Psyga Bio Acquisition and Capital Raise
3M ago
XTL Biopharmaceuticals Wins Conditional Nasdaq Listing Reprieve Tied to Psyga Bio Deal
Premium
Company Announcements
XTL Biopharmaceuticals Wins Conditional Nasdaq Listing Reprieve Tied to Psyga Bio Deal
4M ago
XTL Biopharmaceuticals trading halted, news pending
PremiumThe FlyXTL Biopharmaceuticals trading halted, news pending
5M ago
Upcoming Stock Splits This Week (March 23 to March 27) – Stay Invested
Premium
Market News
Upcoming Stock Splits This Week (March 23 to March 27) – Stay Invested
5M ago
XTL Biopharmaceuticals to Implement One-for-Four ADS Reverse Split Effective March 25, 2026
Premium
Company Announcements
XTL Biopharmaceuticals to Implement One-for-Four ADS Reverse Split Effective March 25, 2026
5M ago
XTL Biopharmaceuticals gets delisting letter from Nasdaq, to request hearing
PremiumThe FlyXTL Biopharmaceuticals gets delisting letter from Nasdaq, to request hearing
6M ago
XTL Biopharmaceuticals Shareholders Approve Capital Increase and NeuroNOS-Linked Private Placement
Premium
Company Announcements
XTL Biopharmaceuticals Shareholders Approve Capital Increase and NeuroNOS-Linked Private Placement
6M ago
XTL Biopharmaceuticals Faces Liquidation of Web Data Subsidiary After Insolvency Ruling
Premium
Company Announcements
XTL Biopharmaceuticals Faces Liquidation of Web Data Subsidiary After Insolvency Ruling
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100